Skip to main content

Want a detailed portfolio tracker?

Tharimmune (THAR) P/E (2024 - 2026)

Tharimmune (THAR) P/E from Jan 2, 2024 to Jul 21, 2026. The TTM Tharimmune (THAR) P/E is -1.24. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Tharimmune (THAR)

YearP/EChange
2026-1.24-57.69%
2025-2.94-4.49%
2024-3.08N/A

Comparison Tharimmune (THAR) P/E with competitors

Tharimmune (THAR) P/E is -1.24.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.35%
ENLVEnlivex Ltd0.07-106.02%
FGENFibroGen Inc0.24-119.31%
CHRSCoherus Biosciences Inc0.85-168.27%
FBIOFortress Biotech Inc0.95-176.36%
ORMPOramed Pharmaceuticals Inc1.50-220.94%
AGENAgenus Inc3.01-342.16%
INVAInnoviva Inc3.15-353.78%
VXRTVaxart Inc3.55-385.62%
CRMDCorMedix Inc3.63-391.95%
CVACCureVac N.V.4.45-457.70%
GLPGGalapagos NV4.86-490.95%
SRPTSarepta Therapeutics Inc4.88-492.82%
ABEOAbeona Therapeutics Inc5.39-533.49%
ABUSArbutus Biopharma Corp5.60-550.23%
ZVRAZevra Therapeutics Inc5.89-573.69%
SPROSpero Therapeutics Inc6.23-601.15%
CGENCompugen Ltd6.31-608.03%
RIGLRigel Pharmaceuticals6.87-652.93%
SLXNSilexion Therapeutics Corp7.30-687.05%
OMEROmeros Corporation9.26-844.97%
AUPHAurinia Pharmaceuticals Inc9.58-871.22%
PLXProtalix BioTherapeutics Inc10.89-976.30%
ACADAcadia Pharmaceuticals Inc11.73-1043.69%
TBPHTheravance Biopharma Inc12.26-1086.63%
ADMAAdma Biologics Inc12.42-1099.18%
HRMYHarmony Biosciences Holdings Inc13.82-1211.99%
SABSSAB Biotherapeutics Inc14.14-1237.42%
NAGENiagen Bioscience Inc14.82-1292.29%
INCYIncyte Corp15.82-1373.11%
REGNRegeneron Pharmaceuticals Inc15.86-1375.85%
PBYIPuma Biotechnology Inc17.32-1493.25%
CPRXCatalyst Pharmaceuticals Inc17.44-1503.19%
EXELExelixis Inc17.54-1511.13%
MDXGMimedx Group Inc20.55-1753.69%
XOMAXOMA Royalty Corp22.87-1940.58%
ARGXArgen X SE24.30-2055.10%
CTMXCytomX Therapeutics Inc24.82-2097.20%
XOMAOXOMA Royalty Corp25.34-2139.33%
HALOHalozyme Therapeutics Inc25.62-2161.78%
XOMAPXOMA Royalty Corp25.67-2165.51%
VRTXVertex Pharmaceuticals Inc27.99-2352.56%
RPRXRoyalty Pharma plc - Class A28.69-2408.30%
SLNOSoleno Therapeutics Inc29.02-2434.68%
ASNDAscendis Pharma A/S30.09-2520.79%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3150.54%
APLSApellis Pharmaceuticals Inc39.02-3239.79%
BMRNBiomarin Pharmaceutical Inc42.21-3496.52%
KRYSKrystal Biotech Inc45.34-3748.50%
ONCBeiGene Ltd69.54-5695.48%
PHARPharming Group N.V.75.03-6136.83%
TECHBio-Techne Corp101.96-8303.94%
VCELVericel Corp109.92-8944.67%
ALNYAlnylam Pharmaceuticals Inc117.96-9591.90%
GMABGenmab140.29-11388.31%
TLXTelix Pharmaceuticals Ltd162.15-13147.41%
CORTCorcept Therapeutics Inc212.86-17227.30%